Healionics Revenue and Competitors
Estimated Revenue & Valuation
- Healionics's estimated annual revenue is currently $3M per year.
- Healionics's estimated revenue per employee is $301,200
- Healionics's total funding is $16.7M.
Employee Data
- Healionics has 10 Employees.
- Healionics grew their employee count by 25% last year.
Healionics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & Chairman | Reveal Email/Phone |
2 | Director & Chief Technology Officer | Reveal Email/Phone |
3 | Quality and Regulatory Engineer | Reveal Email/Phone |
4 | Lead R&D and Quality Engineer | Reveal Email/Phone |
5 | President and COO | Reveal Email/Phone |
6 | clinical trial medical Assistant | Reveal Email/Phone |
7 | Biomaterials Manufacturing Engineer I | Reveal Email/Phone |
Healionics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.9M | 39 | 117% | $14.9M | N/A |
#2 | $44.9M | 143 | -30% | $211.3M | N/A |
#3 | $54M | 172 | 11% | $35.5M | N/A |
#4 | $4.3M | 17 | -19% | N/A | N/A |
#5 | $18.3M | 73 | N/A | N/A | N/A |
#6 | $8.3M | 33 | 6% | N/A | N/A |
#7 | $81.1M | 323 | 17% | N/A | N/A |
#8 | $7M | 28 | -12% | N/A | N/A |
#9 | $204.8M | 816 | 3% | N/A | N/A |
#10 | $6.3M | 50 | 25% | $27.5M | N/A |
What Is Healionics?
Healionics Corporation provides biomaterial solutions to research institutions and medical device manufacturers seeking to enhance the biocompatibility and performance of current and next generation devices. Healionics has exclusive license to breakthrough technologies in biocompatibility created by University of Washington Engineered Biomaterials group (UWEB) over a 9-year period with $30M in funding as a US National Science Foundation Engineering Research Center (NSF ERC). Healionics' initial focus is to supply the innovative STAR material to qualified partners and customers.
keywords:Medical Devices$16.7M
Total Funding
10
Number of Employees
$3M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Healionics News
SEATTLE, May 13, 2021 /PRNewswire/ -- Healionics Corporation, a private medical device company, announced today the completion of a $4.7M equity financing round led by Keiretsu Capital. The company also announced the conversion to equity of $5.2M in previously outstanding notes and interest. ...
Healionics’ STARgraft vascular graft acts as an artificial blood vessel for dialysis patients. (Healionics Photo) New funding: Seattle-based medical technology company Healionics raised a $4.7 million round led by Keiretsu Capital to help commercialize its artificial blood vessel called STARgra ...
Healionics Corporation, a Seattle, WA-based private medical device company, closed a $4.7M equity financing. The round was led by Keiretsu Capital. The company also announced the conversion to equity of $5.2M in previously outstanding notes and interest. Led by Mike Connolly, Chief Executive O ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 10 | 0% | N/A |
#2 | $1.5M | 10 | -89% | N/A |
#3 | $17.5M | 10 | -33% | $221M |
#4 | $0.9M | 10 | N/A | N/A |
#5 | $0.9M | 10 | N/A | N/A |